Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation

NCT04909125 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2026-02-06

No results posted yet for this study

Summary

The purpose of this study is to investigate the difference in fatigue, quality of life and radiation morbidity between hypofractionated and conventional radiation to the breast, chest wall and regional lymph nodes post mastectomy or lumpectomy

Conditions

Interventions

RADIATION

Hypofractionated radiotherapy VS Standard/Conventional fractionation radiotherapy

The purpose of this study is to investigate toxicity following standard conventional fractionation versus moderately hypofractionated radiotherapy to the breast, chest wall and regional lymph nodes

Sponsors & Collaborators

  • Northern Sydney and Central Coast Area Health Service

    collaborator OTHER
  • Royal North Shore Hospital

    lead OTHER

Principal Investigators

  • Susan Carroll, MBBS FRANZCR · Radiation Oncology Department, Royal North Shore Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2024-07-31
Completion
2027-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04909125 on ClinicalTrials.gov